Danish pharmaceutical company Novo Nordisk plans to invest DKK 500m in expanding the company's production facilities near Copenhagen in Denmark, informs the company in a press release Thursday morning.
According to the company, this is to ensure the company's production capacity for the diabetes drug Rybelsus, which is based on the molecule semaglutide.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Hearing firms urge FDA to increase OTC safety requirements
A number of the world’s biggest hearing aid manufacturers have come together to encourage the US health authority to tighten the safety requirements for OTC hearing aids, which will hit the shelves in the US sometime this year.
Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
Coloplast initiates trial of ostomy leakage product
The medtech company will being clinically testing its ostomy add-on product, Heylo, in January.
Top news from MedWatch this week
Miss anything?
Danish bank cuts Genmab price target, retains "buy" recommendation
Jyske Bank has adjusted its valuation of Genmab’s share price target to DKK 2850 (USD 434.4). Investors should continue to buy, the Danish bank says.
QA Specialist, GMP QA 
Senior HR Director, HR Denmark, Ferring 
QA Manager GMP/GDP Compliance & Audits 
Senior Manager, Biostatistics 
NORDIC Medical Sales Director 
Chemists are wanted for ALK's internal Aircraft Corps 
Commercial Excellence Lead 
Senior Quality Assurance Consultant, Denmark 
GxP QA Compliance Manager for Quality Assurance 
Senior Manager/Associate Director Regulatory Affairs 
Senior Scientist 
KLIFO is looking for a Director, Business Support for our Glostrup office 
QA Specialist